SNDX
Syndax Pharmaceuticals, Inc. - Common Stock (SNDX)
$73
About Syndax Pharmaceuticals, Inc. - Common Stock (SNDX)
Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.
Details
Daily high
$9.14
Daily low
$8.58
Price at open
$8.97
52 Week High
$25.07
52 Week Low
$8.58
Market cap
774.4M
Dividend yield
0.00%
Volume
1.8M
Avg. volume
1.8M
P/E ratio
-2.33
Syndax Pharmaceuticals, Inc. - Common Stock News
Details
Daily high
$9.14
Daily low
$8.58
Price at open
$8.97
52 Week High
$25.07
52 Week Low
$8.58
Market cap
774.4M
Dividend yield
0.00%
Volume
1.8M
Avg. volume
1.8M
P/E ratio
-2.33